# Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma

> **NCT04093115** · PHASE2 · WITHDRAWN · sponsor: **Beijing Konruns Pharmaceutical Co., Ltd.**

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** CX1106

## Key facts

- **NCT ID:** NCT04093115
- **Lead sponsor:** Beijing Konruns Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-12-09
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was terminated voluntarily by the sponsor due to changes in clinical development strategy.
- **Last updated:** 2020-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04093115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04093115, "Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04093115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*